Therapeutic and Diagnostic Roles of MSC‐Derived Exosomes in Alzheimer's Disease
Brain and Behavior · 2025-12 · 15 (12)
DOI: 10.1002/brb3.71112 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Behavior, online erschienen am 07.12.2025. Verfasst von Vinay Shankar Patil und 8 weiteren Autor:innen. Beteiligte Einrichtung: Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Exosomes, Mesenchymal Stem Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Purpose
Alzheimer's disease (AD), the leading cause of dementia, is characterized by amyloid‐β accumulation, tau hyperphosphorylation, neuroinflammation, and synaptic failure, with no curative therapies available. This review aims to explore innovative therapeutic and diagnostic strategies, focusing on mesenchymal stem cell–derived exosomes (MSC‐exos) as potential disease‐modifying agents.
Method
The review synthesizes current evidence on the regenerative, immunomodulatory, and neuroprotective properties of mesenchymal stem cells (MSCs) and their exosomes. It examines how MSC‐exos, as nanosized extracellular vesicles carrying proteins, lipids, and nucleic acids, interact with the central nervous system to modulate disease pathways.
Findings
MSC‐exos can cross the blood–brain barrier (BBB), deliver neurotrophic factors, modulate microglial activity, enhance amyloid clearance, and support neuronal survival and synaptic plasticity. They also hold promise as biomarkers by reflecting central nervous system pathology in peripheral biofluids. Early clinical trials using MSCs from bone marrow, adipose tissue, and umbilical cord show safety and feasibility, with exosome‐based approaches offering scalable, cell‐free alternatives.
Conclusion
MSC‐derived exosomes present a promising avenue for both therapeutic intervention and early diagnosis in AD, offering neuroprotective, anti‐inflammatory, and pro‐regenerative effects. However, further progress requires addressing challenges such as exosome isolation standardization, cargo characterization, and regulatory considerations to enable their translation into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York, USA.
- Faculty of Allied Medical Sciences, Hourani Center For Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
- Department of Pharmacology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha, India.
- Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
- College of Pharmacy, the Islamic University, Najaf, Iraq.
Zitieren
APA
Patil, V. S., Parekh, B., Sharma, A., Farah, H., Jyothi-S, R., Mishra, S., Nanda, A., Al-Hasnaawei, S., & Kumar-Mishra, M. (2025). Therapeutic and Diagnostic Roles of MSC‐Derived Exosomes in Alzheimer's Disease. Brain and Behavior, 15(12). https://doi.org/10.1002/brb3.71112
Vancouver
Patil VS, Parekh B, Sharma A, Farah H, Jyothi-S R, Mishra S, et al. Therapeutic and Diagnostic Roles of MSC‐Derived Exosomes in Alzheimer's Disease. Brain and Behavior. 2025;15(12). doi:10.1002/brb3.71112
BibTeX
@article{Patil2025,
author = {Patil, Vinay Shankar and Parekh, Bhavin and Sharma, Amit and Farah, Husni and Jyothi-S, Renuka and Mishra, Swati and Nanda, Anima and Al-Hasnaawei, Shaker and Kumar-Mishra, Manoj},
title = {Therapeutic and Diagnostic Roles of MSC‐Derived Exosomes in Alzheimer's Disease},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {12},
doi = {10.1002/brb3.71112}
}
EUVIMED